Ingen Technologies IGNT · USD

Its shares trade under the ticker IGNT. It has been listed since 11 July 2001. In the fiscal year to 31 May 2015, it reported revenue of $14 and a net loss of $1,012. At that date it held total assets of $319 and shareholders' equity of −$10,814.

Ingen Technologies, Inc. engages in the manufacturing of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm through its subsidiary, Ingen Technologies, Inc., is engaged in medical device manufacturing. The firm manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease (COPD) and requiring oxygen therapy through home healthcare, hospitals, military and government-based medical facilities. The firm manufactures oxygen flow meters and nasal cannulas under Oxyview and Smart Nasal Cannula names. The firm offers both a reusable Oxyview and a disposable Smart Nasal Cannula with Oxyview attached to a nasal cannula. Oxyview is a pneumatic oxygen in-line flow meter. The Smart Nasal Cannula with Oxyview is a disposable nasal cannula that includes the Oxyview assembled and in-line. Oxyview is manufactured in two models: model 206A and model 203A. The Smart Nasal Cannula is available in six models: models 203NCA, 206NCA, 203NCP, 206NCP, 203NCI and 206NCI.

Figures and description from our data supplier, not checked against the company's own report.

• Gary TildenChairman of the Board, Chief Operations Officer, Secretary, since 2011
• David HansonChief Executive Officer, Director, since 2013
• Thomas NeavittChief Financial Officer, Director, since 2004
• Richard CampbellDirector
• Michael CooperDirector
• Dr. John FinazzoDirector
• David HollandDirector
• Yong Sin KhooDirector
• Curt MiedemaDirector
• Donn MillerDirector
• Dr. Stephen O'HaraDirector
• Charles VorwallerDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.